Friday, 9 March 2018

Trading Review: 03-08-2018






















Gross PnL: +$4075.

Net PnL: +$3655. $353 in borrows.

Literally paid through the roof for borrows, but it was well worth it. Unusual for me to have a tonne of primary quality ideas off the bat; and I was forced to focus on what I deemed to be the better ones. Then shift into trading them all as the open came to a close. Would have been nice to catch the downside on CI/ESRX from the open. But am very happy with how I honed in where I needed to.

Definitely could have caught the next leg on CI/ESRX but was a big day and wanted to close it up. Really nice trading around a core on both of them though, it definitely helped maximise profits and protect risk a little bit prior to the breakdowns.

Pump chatroom subscription paid off today. He bought right below my stop-loss on PIXY and couldn't lift it, so I pulled my stop and added to my position - turned out to be the exact peak. Literally the chatroom potentially paid for itself right there (although never actually hit my hard stop anyway).
PIXY was a tad of a wakeup call. A setup like that is prone to squeezes, so I ended up full size slightly earlier than I should have (prior to the add into chatroom buys).

NETE nearly got squeezed out at the highs, the selling was obvious, but it stayed above pm high for a little bit. Pretty solid trading, recognising when it didn't make sense to continue holding the short position (risk-reward wise) resulted in a cover at the lows.

The question with NETE, if I hadn't got the lucky cover what would have happened. My rules dictate that I don't fade moves late in the day, so I like to think I would have stopped at vwap (or even slightly lower around $7.60) - that's definitely the correct move. I hope I would have had the discipline to do that, after watching around $700-$1000 of my profit disappear.

W - lucky cover at the low after recognising that it wasn't a good enough setup to use my mental capital on, while stuff like ESRX/CI was in play. But good trade overall.







No comments:

Post a Comment